chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On and off headaches every day for the past two weeks. On 7/6/2021 and 7/7/2021 had severe nose bleeds. Had headache on 7/8/2021
At 03:48 PM Co Lead PHN was alerted by vaccinator RN that her client needed a medical consult. Client came in today 11/22/2021 for Pfizer COVID-19 vaccine booster dose lot# FF8841. Co Lead PHN found client sitting in chair in vaccination room. Client received Pfizer Covid-19 second dose lot# ER8731 on 04/09/2021. Client stated that 2 hours post vaccination, "I started feeling pressure on my chest. I was having difficulty breathing intermittently but then it resolved within 1-2 hours. I don't recall, it was probably less than 1-2 hours." Client then stated, "the following day when I woke up I started having fever and chills and it self resolved after 1 day." Client did not take any medications for her post vaccination symptoms. Client does not have any medical conditions. Client stated she was possibly stressed that day and disclosed that she is a chemist that works around a lot of chemicals. Client visited PCP one month later to talk about her Pfizer covid-19 second dose post vaccination symptoms. PCP advised client that many of her patients experienced those similar symptoms post covid-19 vaccination and that there was no need to be concerned. 2 months after Pfizer covid-19 second dose client visited PCP again because she had chemical poisoning at her work site. PCP prescribed Albuterol HFA inhaler and currently has it on her person (Co Lead PHN visibly confirmed it was Albuterol HFA). At 03:54 PM observation nurse RN took vitals: BP LA 102/70, pulse 80, O2 SAT 100%, 18 respirations per minute. 4:00 PM Co Lead PHN notified vaccine operations lead RN. Vaccine operations lead RN advised to send a medical consult via text to be forwarded to county doctor for approval due to the client's symptoms occurring within 4 hours post vaccination. At 16:24 Dr. approved Pfizer booster for client. Co Lead PHN notified client and vaccinating RN that county Dr. provided approval to proceed with the Pfizer covid-19 booster vaccination. Co lead PHN recommended for 30 minute observation post vaccination. Client received Pfizer covid-19 booster dose lot# FF8841 at 4:42 PM in left deltoid. Client completed 30 minute observation with no incident. At 5:05 PM client was seen by Co Lead PHN leaving observation room with steady gait.
I started a new deodorant on 12-5-2021. I had an itchy armpit; I kept reapplying the deodorant it was not working well. On Dec. 16th, around that evening I broke out in severe hives. It was all over my body from head to toe. I immediately washed the deodorant off and took a shower and took a Benadryl. When I awoke, I had patches and blotches all on my face. On Saturday, I had itchy welts and sores all over my body. It was extremely red and covered my entire body. I took another Benadryl. I decided to go to the urgent care. The rash was worse around my face, chest, and torso. That evening on Saturday the hives came back and made white welts everywhere. My primary care physician suggested I go to the emergency room. I got a steroid injection, and they gave me a steroid to take for five days. They gave me Pepcid. The rash did not stop, it continued throughout the week. I am off the steroid but am now taking Zyrtec because the rashes are still appearing. Other symptoms were my lips and tongue were itching that Saturday night at midnight.
The next day I started with joint pain in my wrist and low center back .Within a few days the joint pain was in my arms ,elbows, feet and knees . I seen my family physician several times and treated for the pain. I have been referred to a doctor and he is now treating me for the joint pain. I am on a daily prednisone treatment and I have about 75% improvement as of today with treatment.
throat felt funny, she said it felt strange to swallow and that her head felt funny. Administered 25mg Benadryl and gave patient water.
Hospitalization: 3/8/2023 - 3/12/2023 (4 days) Presentation to the ED: fever x2 days COVID + date: 3/8/23 Treatment: Paxlovid Discharge to: HOME. EL9265 2/1/21 EN6202 2/22/21
a 40-year-old patient received MMR II; mumps titer was negative; This spontaneous report was received from a nurse and refers to a 40-year-old, female patient. The patient's medical history, concurrent conditions, concomitant medications, previous drug reactions or allergies were not reported.  On 30-JUL-2021, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) rHA, 1 dose, lot #S035355, expiration date was reported and also validated as 05-NOV-2021 (dose, strength, route of administration and anatomical location were not provided) for prophylaxis (inappropriate age at vaccine administration).  On an unspecified date in 2021, the titer was done. Measles and Rubella titer came back positive but Mumps titer was negative (mumps antibody test negative). The nurse did not know if the patient had received additional measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) doses in the past. No further information was available. The outcome of mumps antibody test negative was not reported (unknown).
Began noticing rapid heart rate and dizziness approximately one hour after getting first dose of COVID vaccine.  Symptoms continued and worsened over next two weeks. Went to ER on April 11th, 2021, due to immense head pressure, BP over 200, and ringing in ears. My blood pressure and heart rate were checked at ER and were high, but came down after laying down for a while. I was given blood pressure medication, Amlodipine, 10 mg tablets. Medication had minor positive effects but symptoms continued to get worse. Returned to ER on April 14th, 2021. Same diagnostic testing was performed. I was given more BP medication and recommendations were made for how to lower blood pressure with diet and exercise.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 51-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Jul2022 at 15:45 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 51 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing), notes: Other medical history: Asthma; "PCOS" (unspecified if ongoing), notes: Other medical history: PCOS; "Thyroid cancer" (unspecified if ongoing), notes: Other medical history: Thyroid cancer; "IDA" (unspecified if ongoing), notes: Other medical history: IDA; "seasonal allergies" (unspecified if ongoing), notes: Other medical history: seasonal allergies; "known allergies: strawberries" (unspecified if ongoing), notes: known allergies: strawberries. Concomitant medication(s) included: NYQUIL, start date: 20Jul2022, stop date: 27Jul2022; MUCINEX, start date: 20Jul2022, stop date: 27Jul2022. Past drug history included: Ceftin, reaction(s): "known allergies: Ceftin", notes: known allergies: Ceftin; Aldactone, reaction(s): "known allergies: Aldactone", notes: known allergies: Aldactone.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. It was reported that the patient received treatment Paxlovid for the treatment of COVID-19 from 21Jul2022 to 25Jul2022.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events drug ineffective and covid-19 and BNT162B2.
Been having rapid heartbeats of 105bpm -120bpm even when resting. Sometimes shortness of breath. Some nausea and light headedness.  A little chest discomfort not chest pain. Usually doesn't last for long but upon getting up out of bed,  I feel a little dizzy. The palpitations are most at night.
196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent.).    No concomitant drug information was provided.  It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine.  No treatment drug information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live Significant follow up-(Case narrative received)
FEVER; HEADACHE; MUSCLE ACHE; NAUSEA; KIDNEY PAIN; This spontaneous report received from a parent concerned a 24 year old male. The patient's weight was 130 pounds, and height was not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported. On an unspecified date, the subject experienced fever, headache, muscle ache, nausea, and kidney pain. Treatment medications (dates unspecified) included: dextromethorphan hydrobromide/doxylamine succinate/ephedrine sulfate/ethanol/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, headache, muscle ache, nausea and kidney pain was not reported. This report was non-serious.
Has a migraine earlier in the day with a scintillating scotoma. Friday, Sunday, Monday during the day I had similar events twice each day. The scotoma subsided and I was left with a headache.
Employees were vaccinated from a vial that was punctured more than 6 hours ago; A spontaneous report was received from a nurse concerning a patient who received Moderna's COVID-19 Vaccine and who experienced an expired product administered.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 22 Dec 2020, a vial containing the Moderna COVID-19 vaccine was punctured.  Instead of being discarded, the vial was placed in cold storage.  On 23 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (LOT number 011J20A) for prophylaxis of COVID-19 infection.   On 27 Dec 2020, the nurse reported that the patient had received the mRNA-1273 vaccine from the vial that was punctured more than 6 hours before administration.  Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not provided.  The event, expired product administered, was considered resolved on 23 Dec 2020.; Reporter's Comments: This case concerns a patient, who experienced an event of expired product administered after receiving the first dose of mRNA-1273 vaccine. No adverse events were reported.
Patient developed fever and headache yesterday, approximately 6 hours after receiving Tdap, Menactra and IPV. Vaccines. Developed hive-like rash on forehead.  She was seen in the emergency room last evening.  Temperature was 99 degrees.  Treated with Tylenol and Benadryl.  Symptoms improved, but she awoke during the night complaining of headache again and chills.  Father went to work this morning.  Received a call from his wife stating that patient feels warm again and is complaining of a headache.  They do not have a thermometer in the home.  Father is unsure if hives have recurred.  Reports that patient has not complained of difficulty breathing or swallowing.  No nausea or vomiting.  No lethargy.  Recommend they monitor her and obtain a thermometer for home use.  Continue  Benadryl and Tylenol or ibuprofen for fever control, as well as increase fluids.  Explained that fever, headache and flulike symptoms can be a normal reaction following immunizations, especially Tdap.  Concern that possible hives a may be an allergic reaction.  If she should develop a fever over 101 or has increased lethargy, nausea, or vomiting, worsening headache or worsening hives,  difficulty breathing or swallowing. I recommended that she be reevaluated in the emergency room or urgent care.  Father agrees with this plan.
Very flu like symptoms body ache, chills, fever, headache and fatigue. Its last for about 3 days.
I got the Flu shot for this year.I cannot answer the above questions as to exactly what it was. This morning after 1/2 walk came home and after bowel movement vomitted bile. Lower back ache.  An hour later another bowel movement followed by nausea and no vomitting. Still nauseous 1/2 later.  I do not drink, use drugs, have not eaten anything unusual, and am in good health until this am.
This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included shingles (51 times since 23rd March 2017). Previously administered products included antibiotic. On an unknown date, the patient received Shingles vaccine and Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had the Shingles shot and the booster shot. The patient had Shingles 51 times. The patient he/she taken antibiotic for several months and I still get the Shingles. The patient would give most anything to stop getting shingles. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Dark Brown urine noted the following morning.  This lasted for four (4) days before subsiding even though I was well hydrated. Pain in my left arm (like a pulled muscle) has not gone away.
I am a fully vaccinated patient who previously had COVID and was just reinfected with the disease; I am a fully vaccinated patient who previously had COVID and was just reinfected with the disease; I am a fully vaccinated patient who previously had COVID and was just reinfected with the disease; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "had COVID" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), DISEASE RECURRENCE (medically significant), outcome "unknown" and all described as "I am a fully vaccinated patient who previously had COVID and was just reinfected with the disease".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Flushed, swollen tongue, red blotchy skin within 60 seconds of receiving vaccine. Administered Epi pen right thigh. EMS was called. EMS checked patient. Patient signed EMS declination for further observation.
Elevated heart rate  (160 bpm) for over an hour. Determined to be AFib and was prescribed Eloquis and motropolol.
Case number PHEH2016US018062, is an initial spontaneous report received from a pharmacist on 13 Jul 2016. This report refers to a patient of an unknown age and gender. Past medical history and concomitant medication were not reported. The patient was vaccinated with influenza vaccine (unknown whether seasonal or pandemic, manufacturer and batch number: not reported) on an unknown date. On an unspecified date, the patient had anaphylactic reaction. The outcome of the event was not reported. The seriousness of the event was reported as serious. The causality of the event was not reported. Case lost to follow up until further follow up.
50 raised, red, fluid-filled bumps (papulomacular) on trunk. Rash also on face, right ear  posterior to.
Shingles symptoms within 24 hours of vaccination: rash on lower mid-back, right side; headache, sensitivity to light, fatigue.  Saw Dermatologist 02 /11/2021, perscribed Valacyclovir,.  This was 2nd bout with Shingles, first experienced in May 2020, two months after onset of COVID-like symptoms which commenced on March 9th, severe for 14 days. Gradual improvement of COVID symptoms (cough, difficult in breathing) after 21 days. Headaches, body aches, difficulty in concentrating, extreme fatigue continued 5 months through August 2020 and resulted in me taking  Leave from full-time job.  COVID antibody test 13 weeks after onset of COVID symptoms was negative.
Injection site soreness, chills, slight fever, aching joints and muscles, leg cramps and headache.
pain in the arm; she had some tiredness soon; This is a spontaneous report from a contactable consumer (patient herself). A 74-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation (at the age of 74years).  Medical history included ongoing bladder infections and ulcer in her vaginal area. Concomitant medication(s) included estrogens conjugated (ESTROGENS CONJUGATED) taken for an unspecified indication.  The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation, Premarin Vaginal cream and Estradiol Vaginal Cream 0.01%. On 06May2021, the patient experienced pain in the arm and, she had some tiredness soon on an unspecified date in 2021. Patient stated, she was using Premarin Cream. She used it last night and this morning when she urinated it smelled like formaldehyde. It stays like that for some time. She has had bladder infections and then thought something was wrong. She talked with her nurse who asked what medications and cream she was using. Then patient made the connection when she used it last night and it smelled like that this morning. Patient and her friend had the shot about 50 days ago. Her friend complained a day or so ago that her arm was hurting and then complained her elbow was hurting yesterday. She didn't think it was related to the vaccine. Then this morning patient's arm was hurting. She clarified shot as Pfizer COVID19 Vaccine and asked if arm pain that long after the vaccine been reported. Urine smelled like formaldehyde: started this morning, but it has happened in the past. It has been going on for 2 weeks since she started using it again. She had used Premarin before and stopped and went to another cream. She doesn't remember any side effects with the other cream. The other cream cost twice as much as Premarin. She states this has been an on going problem. She didn't want to use Premarin before and can't remember why. The Premarin cost 45 and the other cream is 90. Patient clarified the other cream she used was Estradiol Vaginal Cream 0.01%. She used Estradiol and had no issue at all. She bought two tubes and they last 6 months to a year each.  Then she stopped using it because she didn't want to spend the money. The outcome of both the events was unknown.  Follow up attempts are completed. No further information is expected.
Patient formed an acute saddle pulmonary embolism w/acute cor pulmonale (I23.92); Patient had Right Heart CATH & started on blood thinner medications. Patient's recovery & outcome are currently ongoing!
Case number PHEH2013US024533, is an initial spontaneous report from a consumer received on 21 Nov 2013. This report refers to a 73-year-old male patient. Historical conditions included heart attacks and heart failure. No concomitant medication was reported. He was vaccinated with FLUVIRIN (batch number: 1309801) intramuscularly on 24 Oct 2013. On 25 Oct 2013, he experienced cough, running nose, and chest congestion. He felt very congested on 26 Oct 2013 and 27 Oct 2013. On 28 Oct 2013, he went to the physician who stated that he had bronchitis and congestion. Treatment for the events was prescribed as clarithromycin 500mg twice a day. He took clarithromycin 28 Oct 2013 and felt little better. On 29 Oct 2013 he took the second one and did not take any more antibiotics because he felt worse than before. On 30 Oct 2013, he was rushed to the hospital because he unable to move his body and looked like he was going to have stroke. Also he was speechless. On 31 Oct 2013, the patient was transferred to another hospital. A spinal fluid test diagnosed him with Guillain Barre Syndrome. He was discharged from the hospital on 04 Nov 2013. He does not have any symptoms now. The final outcome of the events was not reported. The causality was not reported.
vertigo, dizziness, weakness and fatigue began 8am the following day (18 hours after injection)  lasted all day  Today 2/3/21 dizziness lessened but still present as is fatgue and weakness